Cannabis News

Ayurcann Holdings Corp. (CSE: AYUR) (the " Company ") is pleased to announce the grant of stock options (each an " Option ") and restricted share units (each an " RSU ") pursuant to the Company's stock option plan and restricted share unit plan, respectively.

The Company has granted an aggregate of 705,000 Options and an aggregate of 1,098,682 RSUs to certain directors, officers, employees and consultants of the Company. 75,000 of the Options are exercisable at a price of $0.205 per Option, 230,000 Options are exercisable at a price of $0.38 per Option and the remaining 400,000 Options are exercisable at a price of $0.28 per Option. The Options granted vest in four months and expire on June 30, 2023. Each Option is exercisable to purchase one common share in the capital of the Company. With the exception of the RSUs to the directors which vest immediately, all other RSUs granted vest in four months. All of the RSUs (and any common shares issuable upon redemption) will be subject to applicable securities law hold periods.

About Ayurcann Holdings Corp.

The Company is a leading provider of customized post-harvest outsourcing solutions to licensed cannabis producers. The Company concentrates on the post-harvest requirements of licensed cannabis producers and other brands looking to enter the cannabis market. The Company offers end-to-end full outsourcing solutions including extraction, refinement, formulation, packaging, fulfillment, and distribution.

For additional information, please contact:

Ayurcann Holdings Corp.
Igal Sudman, Chairman, Chief Executive Officer and Corporate Secretary
905.492.3322 x 301
igal@xtrx.ca

Investor Relations:

Ryan Bilodeau
Tel: 416-910-1440
Email: ir@ayurcann.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company's expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company's facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company's business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Curaleaf International Announces Landmark Product Registration in Poland

Latest Move Marks Continued Expansion of European Footprint in Growing Medical Cannabis Market

Curaleaf International (the "Company") part of Curaleaf Holdings (CNSX:CURA), Europe's largest vertically integrated cannabis company, is pleased to announce the successful registration of the Company's cannabis based medicines as extract in Poland, with local partner CanPoland S.A.. Poland is one of the largest medical cannabis markets in Europe by patient population 1 , with a market size expected to be worth at least €2 billion by 2028 2 .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany's Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis

Deal Bolsters Curaleaf Presence and Cements Strategic Advantage in Europe's Largest Market as Germany Readies for Adult Use

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced that Curaleaf International Holdings Limited, the company's European holding company, has signed a definitive agreement to acquire a 55% stake in Four 20 Pharma GmbH, a fully EU-GMP & GDP licensed German producer and distributor of medical cannabis with its own product line.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Reports 2022 Second Quarter Results

Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022

Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
money being thrown away in a wastebasket

Cannabis Waste Hits Record in Canada, How Should Investors Act?

As product destruction from Canadian cannabis operators continues to climb to new heights, how should investors perceive this mounting waste?

New figures from Health Canada, first reported by MJBizDaily, show Canadian cannabis producers destroyed 425 million grams of licensed cannabis last year. On top of that, over 7 million packaged products were destroyed.

The record number of cannabis products destroyed in 2021 was even more than what was sold in the first year of adult-use legalization in Canada, as per the report.

Keep reading...Show less

Curaleaf Reports Second Quarter 2022 Results

Second Quarter 2022 Revenue of $338 Million , an increase of 8% sequentially and YoY

Second Quarter 2022 Adjusted EBITDA (1) of $86 Million , an increase of 18% sequentially and 2% YoY

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Curaleaf Bolsters Executive Leadership Team with Three Key Hires

Ed Kremer Joins as Chief Financial Officer, Camilo Lyon is Named Chief Investment Officer and Mitch Hara Fills New Role of Chief Strategy Officer

- Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, has announced three new hires joining the company's executive leadership team this month. Ed Kremer will join as Chief Financial Officer, Camilo Lyon was named Chief Investment Officer, and Mitch Hara will be Chief Strategy Officer, a new role at the company. Mr. Kremer and Mr. Lyon will begin August 8 and Mr. Hara joined effective August 3 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×